Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Progression in disability and regional grey matter atrophy in relapsing-remitting multiple sclerosis.
Validating a novel web-based method to capture disease progression outcomes in multiple sclerosis.
The role of noninvasive and invasive diagnostic imaging techniques for detection of extra-cranial venous system anomalies and developmental variants.
Association between multiple sclerosis risk-associated SNPs and relapse and disability - a prospective cohort study.
Combination therapy with lenalidomide and nanoceria ameliorates CNS autoimmunity.
[Anti-neurofascin antibody in combined central and peripheral demyelination].
The genetics of Charcot-Marie-Tooth disease: current trends and future implications for diagnosis and management.
Nonconventional MRI and microstructural cerebral changes in multiple sclerosis.
Back and forth in time: Directing age in iPSC-derived lineages.
Transcriptional activity of endogenous retroviruses in multiple sclerosis: a sign of deficient chromatin-mediated silencing.
Oligodendroglial defects during quakingviable cerebellar development.
Endothelin regulates function of IL-17-producing T cell subset.
Reduction in parvalbumin-positive interneurons and inhibitory input in the cortex of mice with experimental autoimmune encephalomyelitis.
Multiple sclerosis: Fingolimod failure in progressive MS INFORMS future trials.
Precision medicine in multiple sclerosis: biomarkers for diagnosis, prognosis, and treatment response.
A descriptive study of prevalence, clinical features and other findings of neuromyelitis optica and neuromyelitis optica spectrum disorder in Khuzestan Province, Iran.
Abnormal galactosylation of immunoglobulin G in cerebrospinal fluid of multiple sclerosis patients.
Circulating Memory T Follicular Helper Cells in Patients with Neuromyelitis Optica/Neuromyelitis Optica Spectrum Disorders.
The search for responsive clinical endpoints in primary progressive multiple sclerosis.
Long-term epidemiology of multiple sclerosis in the Northern Seville District.
[Familial amyloidotic polyneuropathies].
Varicella-zoster virus encephalitis and vasculopathy in a patient treated with fingolimod.
Self-report assessment of fatigue in multiple sclerosis: a critical evaluation.
Combinatorial Effect of Metformin and Lovastatin Impedes T-cell Autoimmunity and Neurodegeneration in Experimental Autoimmune Encephalomyelitis.
Histogram analysis of quantitative T1 and MT maps from ultrahigh field MRI in clinically isolated syndrome and relapsing-remitting multiple sclerosis.
Pages
« first
‹ previous
…
657
658
659
660
661
662
663
664
665
…
next ›
last »